Does CEMIPLIMAB Cause Interstitial lung disease? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Interstitial lung disease have been filed in association with CEMIPLIMAB (LIBTAYO). This represents 0.8% of all adverse event reports for CEMIPLIMAB.
8
Reports of Interstitial lung disease with CEMIPLIMAB
0.8%
of all CEMIPLIMAB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From CEMIPLIMAB?
Of the 8 reports, 2 (25.0%) resulted in death, 6 (75.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEMIPLIMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CEMIPLIMAB Cause?
Fatigue (68)
Pyrexia (49)
Pneumonia (41)
Dyspnoea (40)
Pneumonitis (38)
Off label use (35)
Diarrhoea (34)
Rash (34)
Cytokine release syndrome (33)
Pain (33)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CEMIPLIMAB Alternatives Have Lower Interstitial lung disease Risk?
CEMIPLIMAB vs CEMIPLIMAB-RWLC
CEMIPLIMAB vs CENEGERMIN-BKBJ
CEMIPLIMAB vs CENOBAMATE
CEMIPLIMAB vs CEPHALEXIN
CEMIPLIMAB vs CERITINIB